InvestorsObserver
×
News Home

Is Adagene Inc (ADAG) a Good Choice in Biotechnology Friday?

Friday, January 19, 2024 01:45 PM | InvestorsObserver Analysts

Mentioned in this article

Is Adagene Inc (ADAG) a Good Choice in Biotechnology Friday?

The 78 rating InvestorsObserver gives to Adagene Inc (ADAG) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 95 percent of stocks in the Biotechnology industry, ADAG’s 78 overall rating means the stock scores better than 78 percent of all stocks.

Overall Score - 78
ADAG has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on ADAG!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 78 means the stock is more attractive than 78 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Adagene Inc Stock Today?

Adagene Inc (ADAG) stock is lower by -19.88% while the S&P 500 has gained 1% as of 1:44 PM on Friday, Jan 19. ADAG is down -$0.67 from the previous closing price of $3.37 on volume of 357,058 shares. Over the past year the S&P 500 is higher by 23.85% while ADAG has gained 62.65%. ADAG lost -$0.85 per share the over the last 12 months. Click Here to get the full Stock Report for Adagene Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App